BCWORLD PHARM. Co., Ltd.

A200780

KR7200780005

Pharmaceuticals

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-04-28 pm EDT			5-day change	1st Jan Change
6,170 ^KRW	-0.96%		+1.31%	-4.49%

2023	BCWORLD PHARM. Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
2022	Tranche Update on BCWORLD PHARM. Co., Ltd.'s Equity Buyback Plan announced on August 26, 2022.	CI

Tranche Update on BCWORLD PHARM. Co., Ltd.'s Equity Buyback Plan announced on August 26, 2022.

November 28, 2022 at 09:48 pm EST

From August 26, 2022 to September 30, 2022, the company has repurchased 7,000 shares, representing 0.08% for KRW 62.46 million. With this, the company has completed the repurchase of 7,000 shares, representing 0.08% for KRW 62.46 million under the buyback announced on August 26, 2022.

Latest news about BCWORLD PHARM. Co., Ltd.

BCWORLD PHARM. Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-14	CI
Tranche Update on BCWORLD PHARM. Co., Ltd.'s Equity Buyback Plan announced on August 26, 2022.	22-11-28	CI
Tranche Update on BCWORLD PHARM. Co., Ltd.'s Equity Buyback Plan announced on August 26, 2022.	22-11-28	CI
BCWORLD PHARM. Co., Ltd.'s Equity Buyback announced on August 26 , 2022, has closed with 100,000 shares, representing 1.16% for KRW 806.57 million.	22-11-27	CI
BCWORLD PHARM. Co., Ltd. announces an Equity Buyback for 100,000 shares.	22-08-26	CI
BCWORLD PHARM. Co., Ltd. authorizes a Buyback Plan.	22-08-25	CI
BCWorld Pharm Co., Ltd.(KOSDAQ:A200780) dropped from S&P Global BMI Index	19-09-23	CI
BCWorld Pharm Co., Ltd.'s Equity Buyback announced on July 25, 2019 has expired.	19-08-24	CI
BCWorld Pharm Co., Ltd. announces an Equity Buyback for 35,000 shares, for KRW 547.75 million.	19-07-24	CI
BCWorld Pharm Co., Ltd. authorizes a Buyback Plan.	19-07-24	CI
BCWorld Pharm. Co., Ltd.(KOSDAQ:A200780) added to S&P Global BMI Index	15-09-21	CI
Heon Doo Choi sold 3.15% stake in BCWorld Pharm. Co., Ltd. for KRW 6.7 billion.	15-06-23	CI
Choi, Heon Doo acquired 6.69% stake in BCWorld Pharm. Co., Ltd..	15-05-13	CI
JW Holdings, Chong Kun Dang, Boryung Pharm, and BC World Pharm Sign KRW 200 Billion Agreement with Sudair Pharmaceutical to Export Products to Saudi Arabia Over the Next Five Years	15-03-06	CI
BCWorld Pharm. Co., Ltd. has completed an IPO in the amount of KRW 25.99 billion.	14-12-10	CI
BCWorld Pharm. Co., Ltd. has filed an IPO in the amount of KRW 25.34 billion.	14-08-22	CI

Chart BCWORLD PHARM. Co., Ltd.

Duration

Period

More charts

Company Profile

BCWorldPharm Co Ltd is a Korea-based company mainly engaged in the manufacture and distribution of pharmaceuticals. The Company's products include anesthetic pain medication such as cancer pain treatment, muscle relaxants, anesthesia and pain relief drugs; circulation contracts such as hypertension and hyperlipidemia; antibiotics such as tuberculosis treatment; other prescription drugs such as peptic ulcer and osteoporosis. In addition, the Company develops improved drugs and new products.

Sector

Pharmaceuticals

Calendar

2024-05-13 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
BCWORLD PHARM. CO., LTD.	-4.49%	37.85M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+20.25%	43.75B
OTSUKA HOLDINGS CO., LTD.	+23.88%	22.06B
SANDOZ GROUP AG	+13.30%	14.46B
CIPLA LIMITED	+13.01%	13.62B
ZYDUS LIFESCIENCES LIMITED	+38.08%	11.61B
ONO PHARMACEUTICAL CO., LTD.	-9.32%	6.9B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+9.64%	5.32B